Macrophage inhibitory factor is produced and secreted by MEK inhibition in KRAS mutant CRC cells, and promoting intrinsic resistance through refametinib‐conditioned medium was previously investigated to resolve resistance. The gene discussed is MAP2K7; the disease is colorectal carcinoma.